Status:
COMPLETED
Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery
Lead Sponsor:
Tanta University
Conditions:
Dexmedetomidine
Lidocaine 5% Patch
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Surgery of the knee is a very common procedure which can be very painful and sufficient postoperative pain treatment is often problematic. The aim of this work was to study the effects of supplementat...
Eligibility Criteria
Inclusion
- Adult patients
- ASA I \& II
- Aged between 18 to 60 years
- Weight between 60 to 100 kg
- Scheduled for elective arthroscopic knee surgery
Exclusion
- patient refusal.
- history of cardiac disease.
- impaired renal or hepatic function.
- hypertension treated with α methyldopa, clonidine, or beta-adrenergic blockers.
- if they have used opioid analgesics within the previous 24 hr.
- previous sensitivity to local anesthetics.
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04322760
Start Date
December 1 2016
End Date
December 1 2017
Last Update
March 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.